AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)
$12.71 -0.29 (-2.2308%)
Analysed AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) News Sources
Akari Therapeutics Highlights 1st ASCO Abstract Acceptance
28-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
01-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
02-06-2026
yahoo.com
Akari Therapeutics Releases CEO Corner Reflecting on Evolving ADC Landscape and Akari’s Differentiated PH1 Payload Platform Following ASCO 2026
04-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
04-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week
05-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
09-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
12-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading
15-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
17-06-2026
yahoo.com
What is the current price of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?
The current price of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is $12.71.
AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) since the previous trading day is $-0.29.
AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) since the previous trading day is -2.2308%.
What is the most recent average sentiment score for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?
The most recent average sentiment score for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?
The most recent sentiment for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is .
SEC-8K** Filing Available For AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.